Spencer Kimball, NBC News, July 13, 2022 The Food and Drug Administration has authorized Novavax’s two-dose vaccine for adults ages 18 and over, the fourth Covid shot to get emergency approval in the U.S. since the pandemic began. The FDA decision comes weeks …
Moderna says bivalent vaccine appears to work against omicron subvariants BA.4 and BA.5
Berkeley Lovelace Jr., NBC News, June 22, 2022 An updated version of Moderna’s Covid-19 booster shot appears to work against the fast-spreading omicron subvariants BA.4 and BA.5, the company said in a news release Wednesday. The bivalent vaccine, which Moderna has said it …
Moderna says ‘bivalent’ COVID booster provides stronger protection against omicron
Berkeley Lovelace Jr., NBC News, June 8, 2022 A redesigned version of Moderna’s Covid-19 booster shot appears to provide stronger protection against the omicron variant than its current vaccine, the company said in a news release Wednesday. Early trial results found the bivalent vaccine — …
FDA authorizes Pfizer Covid booster for children 5 to 11 years old
Berkeley Lovelace Jr., NBC News, May 17, 2022 The Food and Drug Administration on Tuesday authorized a booster dose of the Pfizer-BioNTech Covid-19 vaccine for children ages 5 to 11. Children in the age group can get a booster shot at least …
Heart issues more common after COVID infection than vaccination, CDC reports
Erika Edwards, NBC News, April 1, 2022 Compared to vaccination, Covid-19 itself is far more likely to lead to heart problems in teenage boys and young men, the Centers for Disease Control and Prevention reported Friday. The study is the first to …